Intramuscular Injections of Risperidone ISM® for schizophrenia
This study is completed in the United States and in Ukraine. It is testing Intramuscular Injections of Risperidone ISM® for schizophrenia.
SchizophreniaDrugFrom 18 Years to 65 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Risperidone may be useful for adults experiencing schizophrenia.
What would participation involve?
Participants may receive Risperidone, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Ukraine and in the United States.
Who is it mainly for?
This study appears to be mainly for adults with schizophrenia.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: June 2, 2017
Recruitment status
Completed
Enrollment listed in the registry
438
Sponsor
Rovi Pharmaceuticals Laboratories
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Ukraine
Age range
From 18 Years to 65 Years
Official registry ID
NCT03160521
Official title
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT03160521. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Ukraine · 11 sites
Regional Clinical Hospital n.a I.I. Mechnicov
Dnipro
Site status: Not listed — confirm with the team
Kharkiv Regional Clinical Psychiatric Hospital
Kharkiv
Site status: Not listed — confirm with the team
Public Healthcare Institution "Kharkiv Regional Clinical Psychiatric Hospital No. 3", Center of Urgent Psychiatry
Kharkiv
Site status: Not listed — confirm with the team
Kherson Regional Psychiatric Hospital
Kherson
Site status: Not listed — confirm with the team
Kiev City Psychiatric Hospital No. 2
Kiev
Site status: Not listed — confirm with the team
Kyiv Regional Medical Association "Psykhiatriya" in Kyiv
Kiev
Site status: Not listed — confirm with the team
CI Lviv Regional Clinical Psychiatric Hospital. Department 20
Lviv
Site status: Not listed — confirm with the team
CI Lviv Regional Clinical Psychiatric Hospital. Department 25
Lviv
Site status: Not listed — confirm with the team
Odesa Regional Medical Centre of Mental Health
Odesa
Site status: Not listed — confirm with the team
Maltsev Regional Clinical Psychiatric Ho
Poltava
Site status: Not listed — confirm with the team
N.I. Pyrogov Vinnytsya Natl Medical University
Vinnytsia
Site status: Not listed — confirm with the team
United States · 20 sites
Woodland Research Northwest
Rogers, Arkansas
Site status: Not listed — confirm with the team
CIMU Bellflower
Cerritos, California
Site status: Not listed — confirm with the team
Collaborative Neuroscience Network, LLC.
Garden Grove, California
Site status: Not listed — confirm with the team
Synergy Research San Diego
Lemon Grove, California
Site status: Not listed — confirm with the team
Apostle Clinical Trials
Long Beach, California
Site status: Not listed — confirm with the team
NRC Research Institute
Orange, California
Site status: Not listed — confirm with the team
CNRI-Los Angeles LLC
Pico Rivera, California
Site status: Not listed — confirm with the team
CNRI-San Diego
San Diego, California
Site status: Not listed — confirm with the team
Galiz Research
Hialeah, Florida
Site status: Not listed — confirm with the team
Innovative Clinical Research Inc.
Hollywood, Florida
Site status: Not listed — confirm with the team
Atlanta Center for Medical Research
Atlanta, Georgia
Site status: Not listed — confirm with the team
CBH Health LLC
Gaithersburg, Maryland
Site status: Not listed — confirm with the team
Precise Research Centers MS
Flowood, Mississippi
Site status: Not listed — confirm with the team
Altea Research Institute
Las Vegas, Nevada
Site status: Not listed — confirm with the team
Hassman Research Institute
Berlin, New Jersey
Site status: Not listed — confirm with the team
Midwest Clinical Research Center
Dayton, Ohio
Site status: Not listed — confirm with the team
Carolina Clinical Triasl Inc
Charleston, South Carolina
Site status: Not listed — confirm with the team
Community Clinical Research Inc.
Austin, Texas
Site status: Not listed — confirm with the team
InSite Clinical Research
DeSoto, Texas
Site status: Not listed — confirm with the team
Pillar Clinical Research LLC
Richardson, Texas
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Risperidone ISM 75 mg, Risperidone ISM 100 mg, Placebo of Risperidone ISM. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with schizophrenia; age range: From 18 Years to 65 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Rovi Pharmaceuticals Laboratories, which appears to be a pharmaceutical company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
